 Shares of Turning Point Therapeutics Inc NASDAQ: TPTX more than doubled on Friday after Bristol-Myers Squibb Co NYSE: BMY said it will buy the biotech company for 4.10 billion in cash. Bristol-Myers to pay 76 a share for TPTX The pharmaceutical giant is paying 76 a share for Turning Point that represents a 116 premium ... The post Turning Point Therapeutics shares more than doubled on Friday appeared first on Invezz. 